M2 Archive: Preview
You haven't logged in. If you have archive credits in your account, please log in now to use them. If not, you can buy credits in our shopping area.
Apricus Biosciences unveils the first and only on-demand topical treatment of ED in the UK Vitaros
Pharmaceutical company Apricus Biosciences (NasdaqCM:APRI) reported on Monday the market availability of its novel topical on-demand treatment for erectile dysfunction (ED), Vitaros.
The company added that Vitaros will be marketed in the UK by Takeda Pharmaceuticals International GmbH....
If you want to view the full text of this story, you must first purchase archive credits. Return to Archives